Denosumab versus zoledronic acid for treatment of bone metastases in men with castrat

		Cancer Friends Network > Types of Cancer > Bone Cancer
Denosumab versus zoledronic acid for treatment of bone metastases in men with castrat

LinkBack

Thread Tools

Display Modes

#1 (permalink)

02-25-2011, 08:58 PM

cancerfr

Administrator

Join Date: Sep 2008

Posts: 47,337

Denosumab versus zoledronic acid for treatment of bone metastases in men with castrat

Bone metastases are a major burden in men with advanced prostate cancer. We compared denosumab, a human monoclonal antibody against RANKL, with zoledronic acid for prevention of skeletal-related events in men with bone metastases from castration-resistant prostate cancer.

Tim Pearson

« Previous Thread | Next Thread »

Thread Tools
Show Printable Version Email this Page
Display Modes
Linear Mode Switch to Hybrid Mode Switch to Threaded Mode

Posting Rules
You may not post new threads You may not post replies You may not post attachments You may not edit your posts BB code is On Smilies are On [IMG] code is On HTML code is Off Trackbacks are On Pingbacks are On Refbacks are On Forum Rules

All times are GMT. The time now is 06:59 PM.

CancerFriends.net